At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 251 enrolled
Drug / intervention
S-Ibuprofen +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind,Vehicle-Controlled Study to Determine the Efficacy and Safety of AP0302 in the Treatment of Delayed Onset Muscle Soreness (DOMS)
In Brief
A Phase 2 clinical trial evaluating S-Ibuprofen and Vehicle for Pain, Acute. Completed, enrolled 251 participants across 1 site.
Detailed Summary
Phase 2 study designed to evaluated analgesic efficacy and safety of S-Ibuprofen Topical Gel 5%
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Acute
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
201820192020202120222023202420252026
Enrollment StartJan 2018
First PostedFeb 2019
Primary CompletionApr 2019
Study CompletionApr 2019
TodayJul 2026
First PostedFeb 25, 2019
Enrollment StartJan 12, 2018
Primary CompletionApr 4, 2019
Study CompletionApr 11, 2019
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 7.4 years ago
Interventions
S-Ibuprofendrug
Topical Gel 5%
Vehicledrug
Vehicle Gel